Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07353905 · ClinicalTrials.gov registry record · NA
Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
A NA study of Peripheral Arterial Disease and Lower Extremity Arterial Disease, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 6
- Study locations
NCT07353905: Recruiting NA study of Peripheral Arterial Disease and Lower Extremity Arterial Disease, sponsored by Baylor Research Institute.
NCT07353905 is a NA study of Peripheral Arterial Disease and Lower Extremity Arterial Disease that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 350 participants, below the 4,202-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (92% lower). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07353905, a NA study of Peripheral Arterial Disease and Lower Extremity Arterial Disease, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study will test whether using ultrasound imaging within blood vessels during minimally invasive treatment of leg arteries in patients with peripheral artery disease leads to better clinical outcomes.
Primary Outcome
Freedom from restenosis ≥50% or an increase in Duplex Ultrasound peak systolic velocity ≥2.5 times reference proximal segment or target lesion revascularization (TLR).
Conditions Studied
Interventions
- DEVICE Intravascular Ultrasound (IVUS)
- DEVICE Angiographic-guided Intervention
Study Locations (6)
Texas
- Baylor Scott & White The Heart Hospital - Dallas - Dallas
- Baylor Scott & White The Heart Hospital - Fort Worth - Fort Worth
- Baylor Scott & White The Heart Hospital - Mckinney - McKinney
- The Heart Hospital Baylor Plano - Plano
- Baylor Scott & White Medical Center - Temple - Temple
- Baylor Scott & White The Heart Hospital - Waxahachie - Waxahachie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2025-12-12 |
| Est. Completion | 2028-07 |
| Phase | NA |
What NCT07353905 shows while recruiting
NCT07353905 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 4,202-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Intravascular Ultrasound (IVUS) is the first listed.
NCT07353905 lists 6 locations in 1 state (Texas).
Frequently Asked Questions
What is clinical trial NCT07353905 about?
NCT07353905 is a clinical study titled "Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries". This study will test whether using ultrasound imaging within blood vessels during minimally invasive treatment of leg arteries in patients with peripheral artery disease leads to better clinical outcomes.
What is the current status of trial NCT07353905?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2025-12-12. Estimated completion is 2028-07.
What conditions does trial NCT07353905 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Lower Extremity Arterial Disease.
What interventions are being tested in trial NCT07353905?
The interventions under investigation include: Intravascular Ultrasound (IVUS) (DEVICE), Angiographic-guided Intervention (DEVICE).
Who is sponsoring clinical trial NCT07353905?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07353905 being conducted?
This trial has 6 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07353905's enrollment target sits among peer trials
350 12th of 79 higher than 67 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI